Ernie Mario

(DR. Ernest Mario Ph.D.)

Currently holds positions in Eyenovia Inc, Soleno Therapeutics Inc and Kindred Biosciences Inc

Positions

Position Company Period
Director Eyenovia Inc None -
Independent Chairman of the Board Soleno Therapeutics Inc Feb. 1, 2014 -
Independent Director Kindred Biosciences Inc April 2, 2018 -
Independent Director Celgene Corp Aug. 22, 2007 - Nov. 20, 2019
Independent Director Tonix Pharmaceuticals Holding Corp Oct. 14, 2011 - Sept. 5, 2018
Independent Chairman of the Board Chimerix Inc Feb. 1, 2013 - June 1, 2018
Independent Director Kindred Biosciences Inc Feb. 15, 2013 - May 23, 2016
Independent Director Boston Scientific Corp Oct. 30, 2001 - April 15, 2016
Lead Independent Director Pharmaceutical Product Development Inc July 1, 2009 - Jan. 1, 2016
Director XenoPort Inc June 15, 2012 - May 19, 2015
Chairman & CEO Soleno Therapeutics Inc Aug. 1, 2007 - Feb. 1, 2014
Independent Director Maxygen Inc July 20, 2001 - Aug. 29, 2013
Independent Director Vivus Inc April 18, 2012 - July 19, 2013
Ernie Mario's trades of Soleno Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-04-04 2022-03-31
B Purchase
930,000
0.00
USD 0 		930,000 0.00 USD 0
2022-04-04 2022-03-31
B Purchase
930,000
0.00
USD 0 		930,000 0.00 USD 0
2020-03-26 2020-03-24
US Eyenovia Inc (EYEN)
B Purchase
82,431 +33.7%
2.27
USD 187,118 		82,431 +33.7% 2.27 USD 187,118
2019-07-15 2019-07-11
US Eyenovia Inc (EYEN)
B Purchase
35,971 +15.2%
2.78
USD 99,999 		35,971 +15.2% 2.78 USD 99,999
2019-02-14 2019-02-12
US Celgene Corp (CELG)
B Purchase
2,000 +inf%
89.99
USD 179,980 		2,000 +inf% 89.99 USD 179,980
2019-05-21 2018-01-29
US Eyenovia Inc (EYEN)
B Purchase
90,000 +61.3%
10.00
USD 900,000 		90,000 +61.3% 10.00 USD 900,000
2016-12-29 2016-12-27
US Chimerix Inc (CMRX)
PS Planned sale
72,073 -19.6%
4.68
USD 337,143 		72,073 -19.6% 4.68 USD 337,143
2016-08-19 2016-08-18
B Purchase
25,000 +1.4%
0.99
USD 24,750 		25,000 +1.4% 0.99 USD 24,750
2016-05-23 2016-05-20
B Purchase
5,637 +0.3%
1.20
USD 6,764 		5,637 +0.3% 1.20 USD 6,764
2015-08-25 2015-08-21
B Purchase
16,228 +1.1%
1.91
USD 30,995 		16,228 +1.1% 1.91 USD 30,995
2015-08-12 2015-08-11
B Purchase
50,000 +3.9%
1.77
USD 88,500 		50,000 +3.9% 1.77 USD 88,500
2004-05-05 2004-05-05
B Purchase
20,000 +39.7%
13.00
USD 260,000 		20,000 +39.7% 13.00 USD 260,000
2004-05-06 2004-05-04
B Purchase
500 +0.5%
39.86
USD 19,930 		500 +0.5% 39.86 USD 19,930
2004-05-06 2004-05-04
B Purchase
2,200 +2.1%
39.85
USD 87,670 		2,200 +2.1% 39.85 USD 87,670
// ... existing code ... // ... rest of the file ...